November 25, 2010Cardiovascular Therapeutics

Aliskiren in the Treatment of Hypertension and Organ Damage

View Full Paper

Ask AI

Bookmark

Why the study?

Does aliskiren improve cardiovascular and renal outcomes in patients with hypertension?

Population

Patients with hypertension and cardiovascular or renal diseases

Design

Review

Authors

GRGraziano RiccioniEllis Hospital

Discussion

Member takes

Implication

Does not support aliskiren adoption in hypertension; leaves open whether enhanced RAAS control reduces clinical events.

Structured PICO

Does aliskiren improve cardiovascular and renal outcomes in patients with hypertension?

Population

Patients with hypertension and cardiovascular or renal diseases

Intervention

Aliskiren (direct renin inhibitor)

Outcome

Efficacy, safety, tolerability, and potential organ protection benefits

Aliskiren offers the potential for enhanced RAAS control and organ protection in hypertension, with ongoing trials testing its efficacy in reducing major clinical events.

Cite This Study

Graziano Riccioni (2010) studied this question.

synapsesocial.com/papers/6a6fde3031a3df8243282c2c https://doi.org/10.1111/j.1755-5922.2010.00230.x

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Aliskiren in the Treatment of Hypertension and Organ Damage

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Aliskiren in the Treatment of Hypertension and Organ Damage

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider